Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	CTP synthase activity	CTPS2 CTPS1	3.29e-05	2	115	2	GO:0003883
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH6 DNAH9 DNAH11	1.43e-04	18	115	3	GO:0008569
GeneOntologyCellularComponent	cytoophidium	CTPS2 CTPS1	8.51e-05	3	112	2	GO:0097268
GeneOntologyCellularComponent	chromatoid body	TDRD5 PIWIL1 TDRD6	9.64e-05	17	112	3	GO:0033391
GeneOntologyCellularComponent	myosin filament	MYH9 MYH15 MYOM2	3.16e-04	25	112	3	GO:0032982
GeneOntologyCellularComponent	cortical granule	HEXB MYH9	4.21e-04	6	112	2	GO:0060473
GeneOntologyCellularComponent	pole plasm	TDRD5 PIWIL1 TDRD6	4.94e-04	29	112	3	GO:0045495
GeneOntologyCellularComponent	germ plasm	TDRD5 PIWIL1 TDRD6	4.94e-04	29	112	3	GO:0060293
GeneOntologyCellularComponent	P granule	TDRD5 PIWIL1 TDRD6	4.94e-04	29	112	3	GO:0043186
GeneOntologyCellularComponent	contractile muscle fiber	FLNB FLNC IDO1 GRK3 MYH15 MYOM2 NOS1	9.64e-04	290	112	7	GO:0043292
GeneOntologyCellularComponent	endocytic vesicle	CYBB FLNB MYH9 HP PIK3C3 CLTB FTH1 CCL2	1.09e-03	384	112	8	GO:0030139
GeneOntologyCellularComponent	cluster of actin-based cell projections	TRPM6 FLNB MYH9 TMC1 IDO1 PRKCB	1.29e-03	223	112	6	GO:0098862
Domain	CTP_synthase_N	CTPS2 CTPS1	3.63e-05	2	113	2	IPR017456
Domain	GATase1_CTP_Synthase	CTPS2 CTPS1	3.63e-05	2	113	2	IPR033828
Domain	CTP_synthase	CTPS2 CTPS1	3.63e-05	2	113	2	IPR004468
Domain	CTP_synth_N	CTPS2 CTPS1	3.63e-05	2	113	2	PF06418
Domain	Dynein_heavy_chain_D4_dom	DNAH6 DNAH9 DNAH11	7.48e-05	14	113	3	IPR024317
Domain	Dynein_HC_stalk	DNAH6 DNAH9 DNAH11	7.48e-05	14	113	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH6 DNAH9 DNAH11	7.48e-05	14	113	3	IPR013602
Domain	DHC_N2	DNAH6 DNAH9 DNAH11	7.48e-05	14	113	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH6 DNAH9 DNAH11	7.48e-05	14	113	3	IPR011704
Domain	MT	DNAH6 DNAH9 DNAH11	7.48e-05	14	113	3	PF12777
Domain	AAA_8	DNAH6 DNAH9 DNAH11	7.48e-05	14	113	3	PF12780
Domain	AAA_5	DNAH6 DNAH9 DNAH11	7.48e-05	14	113	3	PF07728
Domain	DHC_fam	DNAH6 DNAH9 DNAH11	9.31e-05	15	113	3	IPR026983
Domain	Dynein_heavy	DNAH6 DNAH9 DNAH11	9.31e-05	15	113	3	PF03028
Domain	Dynein_heavy_dom	DNAH6 DNAH9 DNAH11	9.31e-05	15	113	3	IPR004273
Domain	CX3CL1	CCL2 CCL13	2.16e-04	4	113	2	IPR008097
Domain	GATase	CTPS2 CTPS1	3.59e-04	5	113	2	PF00117
Domain	GATASE_TYPE_1	CTPS2 CTPS1	5.36e-04	6	113	2	PS51273
Domain	GATASE	CTPS2 CTPS1	5.36e-04	6	113	2	IPR017926
Domain	MHC_II_a_N	HLA-DMA HLA-DMB	7.47e-04	7	113	2	IPR001003
Domain	DHC_N1	DNAH9 DNAH11	9.92e-04	8	113	2	PF08385
Domain	TMC	TMC1 TMC3	9.92e-04	8	113	2	PF07810
Domain	Dynein_heavy_dom-1	DNAH9 DNAH11	9.92e-04	8	113	2	IPR013594
Domain	TMC	TMC1 TMC3	9.92e-04	8	113	2	IPR012496
Domain	GPS	ADGRG4 ADGRG6 ADGRL2	1.13e-03	34	113	3	SM00303
Domain	GPCR_2_secretin-like_CS	ADGRG4 ADGRG6 ADGRL2	1.13e-03	34	113	3	IPR017983
Domain	GPS	ADGRG4 ADGRG6 ADGRL2	1.23e-03	35	113	3	PF01825
Domain	GPS	ADGRG4 ADGRG6 ADGRL2	1.33e-03	36	113	3	PS50221
Domain	GPS	ADGRG4 ADGRG6 ADGRL2	1.44e-03	37	113	3	IPR000203
Domain	IG_FLMN	FLNB FLNC	1.58e-03	10	113	2	SM00557
Domain	-	CTPS2 CTPS1	1.58e-03	10	113	2	3.40.50.880
Domain	PTX	ADGRG4 ADGRG6	1.58e-03	10	113	2	SM00159
Domain	RGS	MYH9 RGS18 GRK3	1.68e-03	39	113	3	IPR016137
Domain	GPCR_2_extracellular_dom	ADGRG4 ADGRG6 ADGRL2	1.81e-03	40	113	3	IPR001879
Domain	G_PROTEIN_RECEP_F2_1	ADGRG4 ADGRG6 ADGRL2	1.81e-03	40	113	3	PS00649
Domain	G_PROTEIN_RECEP_F2_3	ADGRG4 ADGRG6 ADGRL2	1.81e-03	40	113	3	PS50227
Domain	P-loop_NTPase	MYH9 SLFN14 RND3 SPATA17 CTPS2 SULT1C3 MYH15 RND2 CTPS1 DNAH6 DNAH9 HYDIN DNAH11	1.84e-03	848	113	13	IPR027417
Domain	Filamin	FLNB FLNC	1.93e-03	11	113	2	PF00630
Domain	FILAMIN_REPEAT	FLNB FLNC	1.93e-03	11	113	2	PS50194
Domain	Filamin/ABP280_rpt	FLNB FLNC	1.93e-03	11	113	2	IPR001298
Domain	Filamin/ABP280_repeat-like	FLNB FLNC	1.93e-03	11	113	2	IPR017868
Domain	Pentaxin-related	ADGRG4 ADGRG6	1.93e-03	11	113	2	IPR001759
Domain	Pentaxin	ADGRG4 ADGRG6	1.93e-03	11	113	2	PF00354
Domain	Class_I_gatase-like	CTPS2 CTPS1	2.30e-03	12	113	2	IPR029062
Domain	SAM_DOMAIN	PPFIBP2 MAP3K20 DGKH GAREM1	2.65e-03	95	113	4	PS50105
Domain	SAM	PPFIBP2 MAP3K20 DGKH GAREM1	2.86e-03	97	113	4	IPR001660
Domain	TUDOR	TDRD5 TDRD6	3.15e-03	14	113	2	PF00567
Domain	7tm_2	ADGRG4 ADGRG6 ADGRL2	3.44e-03	50	113	3	PF00002
Domain	G_PROTEIN_RECEP_F2_2	ADGRG4 ADGRG6 ADGRL2	3.44e-03	50	113	3	PS00650
Domain	PI3/4_kinase_CS	PIK3C3 ATM	3.62e-03	15	113	2	IPR018936
Domain	Myosin_N	MYH9 MYH15	3.62e-03	15	113	2	PF02736
Domain	Myosin_N	MYH9 MYH15	3.62e-03	15	113	2	IPR004009
Domain	-	PIK3C3 ATM	4.12e-03	16	113	2	1.10.1070.11
Domain	PI3Kc	PIK3C3 ATM	4.12e-03	16	113	2	SM00146
Domain	Myosin_tail_1	MYH9 MYH15	5.21e-03	18	113	2	PF01576
Domain	Myosin_tail	MYH9 MYH15	5.21e-03	18	113	2	IPR002928
Domain	PI3_PI4_kinase	PIK3C3 ATM	5.21e-03	18	113	2	PF00454
Domain	PI3_4_KINASE_1	PIK3C3 ATM	5.21e-03	18	113	2	PS00915
Domain	PI3_4_KINASE_2	PIK3C3 ATM	5.21e-03	18	113	2	PS00916
Domain	PI3/4_kinase_cat_dom	PIK3C3 ATM	5.21e-03	18	113	2	IPR000403
Domain	PI3_4_KINASE_3	PIK3C3 ATM	5.21e-03	18	113	2	PS50290
Domain	SAM/pointed	PPFIBP2 MAP3K20 DGKH GAREM1	5.58e-03	117	113	4	IPR013761
Domain	Kinase-like_dom	TRPM6 MAP3K14 MAP3K20 GRK3 GUCY2C PIK3C3 ULK4 PRKCB ATM	5.65e-03	542	113	9	IPR011009
Domain	GPCR_2_secretin-like	ADGRG4 ADGRG6 ADGRL2	5.74e-03	60	113	3	IPR000832
Domain	GPCR_2-like	ADGRG4 ADGRG6 ADGRL2	5.74e-03	60	113	3	IPR017981
Domain	Myosin-like_IQ_dom	MYH9 MYH15	5.80e-03	19	113	2	IPR027401
Domain	-	MYH9 MYH15	5.80e-03	19	113	2	4.10.270.10
Domain	Fd_Rdtase_FAD-bd	CYBB NOS1	5.80e-03	19	113	2	IPR017927
Domain	PLAC	ADAMTS12 ADAMTS16	5.80e-03	19	113	2	PS50900
Domain	FAD_FR	CYBB NOS1	5.80e-03	19	113	2	PS51384
Domain	PLAC	ADAMTS12 ADAMTS16	5.80e-03	19	113	2	IPR010909
Domain	Riboflavin_synthase-like_b-brl	CYBB NOS1	5.80e-03	19	113	2	IPR017938
Domain	G_PROTEIN_RECEP_F2_4	ADGRG4 ADGRG6 ADGRL2	6.02e-03	61	113	3	PS50261
Pubmed	Clustering of Genetic Anomalies of Cilia Outer Dynein Arm and Central Apparatus in Patients with Transposition of the Great Arteries.	DNAH9 HYDIN DNAH11	1.41e-07	4	115	3	36140829
Pubmed	Hemolysis-induced lethality involves inflammasome activation by heme.	CYBB FTH1 IL1R1	1.95e-06	8	115	3	25225402
Pubmed	Uncovering the Translational Regulatory Activity of the Tumor Suppressor BRCA1.	BRCA1 DZIP3 GOLGA8A	2.92e-06	9	115	3	32290274
Pubmed	USP19 deubiquitinating enzyme supports cell proliferation by stabilizing KPC1, a ubiquitin ligase for p27Kip1.	FLNB FLNC MYH9	5.70e-06	11	115	3	19015242
Pubmed	Damage-induced ubiquitylation of human RNA polymerase II by the ubiquitin ligase Nedd4, but not Cockayne syndrome proteins or BRCA1.	ITCH WWP1 BRCA1	5.70e-06	11	115	3	17996703
Pubmed	Dynamics of major histocompatibility complex class II compartments during B cell receptor-mediated cell activation.	HEXB HLA-DMA HLA-DMB	5.70e-06	11	115	3	11854359
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	TPP2 NCAPD3 NRDC CUL7 PIK3C3 MKI67 MED17	7.11e-06	212	115	7	33853758
Pubmed	Docking motif-guided mapping of the interactome of protein phosphatase-1.	MKI67 DZIP3 PPP1R36 HYDIN KNL1	7.14e-06	80	115	5	19389623
Pubmed	WDR62 is required for centriole duplication in spermatogenesis and manchette removal in spermiogenesis.	TDRD5 PIWIL1 MKI67 TDRD6	7.68e-06	38	115	4	34059773
Pubmed	A new human HLA class II-related locus, DM.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	1922365
Pubmed	New class II-like genes in the murine MHC.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	1922366
Pubmed	Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and function.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	9551909
Pubmed	Factor VII-activating protease deficiency promotes neointima formation by enhancing leukocyte accumulation.	CCL2 HABP2	1.08e-05	2	115	2	27431088
Pubmed	Mechanisms of increased risk of tumorigenesis in Atm and Brca1 double heterozygosity.	BRCA1 ATM	1.08e-05	2	115	2	21849032
Pubmed	Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	8849454
Pubmed	Protein kinase C beta is required for human monocyte chemotaxis to MCP-1.	CCL2 PRKCB	1.08e-05	2	115	2	12724308
Pubmed	Constitutive activation of the ATM/BRCA1 pathway prevents DNA damage-induced apoptosis in 5-azacytidine-resistant cell lines.	BRCA1 ATM	1.08e-05	2	115	2	24680865
Pubmed	HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	8139690
Pubmed	Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	11956296
Pubmed	ATM kinase activity modulates ITCH E3-ubiquitin ligase activity.	ITCH ATM	1.08e-05	2	115	2	23435430
Pubmed	HLA-DMA0103 and HLA-DMB0104 alleles as novel prognostic factors in rheumatoid arthritis.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	15547082
Pubmed	DM influences the abundance of major histocompatibility complex class II alleles with low affinity for class II-associated invariant chain peptides via multiple mechanisms.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	20408893
Pubmed	Association of HLA-DM polymorphism with the production of antiphospholipid antibodies.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	15547089
Pubmed	Comparison of collagen propeptides as growth markers in children with inflammatory bowel disease.	BRCA1 ATM	1.08e-05	2	115	2	2001833
Pubmed	[HLA-DM polymorphisms in Guizhou Han individuals].	HLA-DMA HLA-DMB	1.08e-05	2	115	2	18779172
Pubmed	The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	10631952
Pubmed	Characterization of polymorphism within the H2-M MHC class II loci.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	7607704
Pubmed	14-3-3 proteins regulate cullin 7-mediated Eag1 degradation.	CUL7 KCNH1	1.08e-05	2	115	2	36717938
Pubmed	Analysis of HLA-DM polymorphisms in the Chinese Han population.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	22309257
Pubmed	[Association of human leukocyte antigen non-classical genes with type 1 diabetes].	HLA-DMA HLA-DMB	1.08e-05	2	115	2	14754527
Pubmed	[Relationship of trichloroethylene-induced medicamentosa like dermatitis to HLA-DMA and HLA-DMB].	HLA-DMA HLA-DMB	1.08e-05	2	115	2	16737583
Pubmed	HLA-DM polymorphism and risk of trichloroethylene induced medicamentosa-like dermatitis.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	18348411
Pubmed	Mapping of a myosin-binding domain and a regulatory phosphorylation site in M-protein, a structural protein of the sarcomeric M band.	MYH9 MYOM2	1.08e-05	2	115	2	9529381
Pubmed	Role for ATM in DNA damage-induced phosphorylation of BRCA1.	BRCA1 ATM	1.08e-05	2	115	2	10866324
Pubmed	NMDA receptor activation increases free radical production through nitric oxide and NOX2.	CYBB NOS1	1.08e-05	2	115	2	19244529
Pubmed	HLA-DM is expressed on the cell surface and colocalizes with HLA-DR and invariant chain in human Langerhans cells.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	9879837
Pubmed	Atm heterozygosity cooperates with loss of Brca1 to increase the severity of mammary gland cancer and reduce ductal branching.	BRCA1 ATM	1.08e-05	2	115	2	16204043
Pubmed	Human germinal center B cells differ from naive and memory B cells by their aggregated MHC class II-rich compartments lacking HLA-DO.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	12663675
Pubmed	Editing of the HLA-DR-peptide repertoire by HLA-DM.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	8947036
Pubmed	Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	11743588
Pubmed	Limited polymorphism in HLA-DM does not involve the peptide binding groove.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	8225438
Pubmed	Therapeutic hypothermia augments the restorative effects of PKC-β and Nox2 inhibition on an in vitro model of human blood-brain barrier.	CYBB PRKCB	1.08e-05	2	115	2	34398388
Pubmed	Genomic organization of HLA-DMA and HLA-DMB. Comparison of the gene organization of all six class II families in the human major histocompatibility complex.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	8034636
Pubmed	Regulation of human cytidine triphosphate synthetase 2 by phosphorylation.	CTPS2 CTPS1	1.08e-05	2	115	2	20739275
Pubmed	[HLA-DM gene polymorphism in Cantonese with condyloma acuminata].	HLA-DMA HLA-DMB	1.08e-05	2	115	2	16864101
Pubmed	HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	21131964
Pubmed	A novel human actin-binding protein homologue that binds to platelet glycoprotein Ibalpha.	FLNB FLNC	1.08e-05	2	115	2	9694715
Pubmed	Human duodenal epithelial cells constitutively express molecular components of antigen presentation but not costimulatory molecules.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	12392850
Pubmed	Impaired skin and mammary gland development and increased gamma-irradiation-induced tumorigenesis in mice carrying a mutation of S1152-ATM phosphorylation site in Brca1.	BRCA1 ATM	1.08e-05	2	115	2	19996295
Pubmed	piRNA loading triggers MIWI translocation from the intermitochondrial cement to chromatoid body during mouse spermatogenesis.	PIWIL1 TDRD6	1.08e-05	2	115	2	38491008
Pubmed	Regulation of MHC class II antigen presentation by sorting of recycling HLA-DM/DO and class II within the multivesicular body.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	11441095
Pubmed	H2-M polymorphism in mice susceptible to collagen-induced arthritis involves the peptide binding groove.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	8613139
Pubmed	Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.	BRCA1 ATM	1.08e-05	2	115	2	29665859
Pubmed	The limits of promiscuity: isoform-specific dimerization of filamins.	FLNB FLNC	1.08e-05	2	115	2	12525170
Pubmed	Ubiquitination of human leukocyte antigen (HLA)-DM by different membrane-associated RING-CH (MARCH) protein family E3 ligases targets different endocytic pathways.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	22247549
Pubmed	The DMalpha and DMbeta chain cooperate in the oxidation and folding of HLA-DM.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	17015729
Pubmed	Expression of DNA double-strand break repair proteins ATM and BRCA1 predicts survival in colorectal cancer.	BRCA1 ATM	1.08e-05	2	115	2	16533773
Pubmed	Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.	BRCA1 ATM	1.08e-05	2	115	2	10550055
Pubmed	Hemizygosity for Atm and Brca1 influence the balance between cell transformation and apoptosis.	BRCA1 ATM	1.08e-05	2	115	2	20175908
Pubmed	Birthdating of myenteric neuron subtypes in the small intestine of the mouse.	MKI67 NOS1	1.08e-05	2	115	2	23861145
Pubmed	The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	9768757
Pubmed	Crystal structure of mouse H2-M.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	9768758
Pubmed	HLA-DM - an endosomal and lysosomal chaperone for the immune system.	HLA-DMA HLA-DMB	1.08e-05	2	115	2	10322421
Pubmed	Identification and characterization of proteins interacting with Traf4, an enigmatic p53 target.	GPRASP1 MYH9 FTH1	1.91e-05	16	115	3	16969126
Pubmed	RNF11 sequestration of the E3 ligase SMURF2 on membranes antagonizes SMAD7 down-regulation of transforming growth factor β signaling.	ITCH WWP1 DZIP3	2.32e-05	17	115	3	28292929
Pubmed	Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study.	BRCA1 ATM	3.24e-05	3	115	2	15084244
Pubmed	Expression of Human CTP synthetase in Saccharomyces cerevisiae reveals phosphorylation by protein kinase A.	CTPS2 CTPS1	3.24e-05	3	115	2	16179339
Pubmed	A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein.	BRCA1 ATM	3.24e-05	3	115	2	12773400
Pubmed	SNM1A acts downstream of ATM to promote the G1 cell cycle checkpoint.	DCLRE1B ATM	3.24e-05	3	115	2	18848520
Pubmed	Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress.	BRCA1 ATM	3.24e-05	3	115	2	11114888
Pubmed	Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response.	BRCA1 ATM	3.24e-05	3	115	2	10910365
Pubmed	Promoter Methylation of PRKCB, ADAMTS12, and NAALAD2 Is Specific to Prostate Cancer and Predicts Biochemical Disease Recurrence.	ADAMTS12 PRKCB	3.24e-05	3	115	2	34198725
Pubmed	Polymorphism of HLA-DMA and DMB alleles in patients with systemic lupus erythematosus.	HLA-DMA HLA-DMB	3.24e-05	3	115	2	12858445
Pubmed	Lymph node stromal CCL2 limits antibody responses.	CYBB CCL2	3.24e-05	3	115	2	32198221
Pubmed	Adenovirus protein involved in virus internalization recruits ubiquitin-protein ligases.	ITCH WWP1	3.24e-05	3	115	2	12450395
Pubmed	miR-511-3p protects against cockroach allergen-induced lung inflammation by antagonizing CCL2.	MRC1 CCL2	3.24e-05	3	115	2	31536479
Pubmed	Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy.	BRCA1 ATM	3.24e-05	3	115	2	25205036
Pubmed	TDRD5 binds piRNA precursors and selectively enhances pachytene piRNA processing in mice.	TDRD5 PIWIL1	3.24e-05	3	115	2	29317670
Pubmed	Endogenous hSNM1B/Apollo interacts with TRF2 and stimulates ATM in response to ionizing radiation.	DCLRE1B ATM	3.24e-05	3	115	2	18468965
Pubmed	Filamin A and Filamin B are co-expressed within neurons during periods of neuronal migration and can physically interact.	FLNB FLNC	3.24e-05	3	115	2	12393796
Pubmed	Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk.	ULK4 DNAH11	3.24e-05	3	115	2	22120009
Pubmed	Genomic structure and fine mapping of the two human filamin gene paralogues FLNB and FLNC and comparative analysis of the filamin gene family.	FLNB FLNC	3.24e-05	3	115	2	11153914
Pubmed	ATR/ATM-Mediated Phosphorylation of BRCA1 T1394 Promotes Homologous Recombinational Repair and G2-M Checkpoint Maintenance.	BRCA1 ATM	3.24e-05	3	115	2	34301763
Pubmed	PTP1B up-regulates EGFR expression by dephosphorylating MYH9 at Y1408 to promote cell migration and invasion in esophageal squamous cell carcinoma.	MYH9 PTPN1	3.24e-05	3	115	2	31735331
Pubmed	Prediction of BRCA1 germ-line mutation status in patients with breast cancer using histoprognosis grade, MS110, Lys27H3, vimentin, and KI67.	BRCA1 MKI67	3.24e-05	3	115	2	23614934
Pubmed	Double-strand break repair by homologous recombination in primary mouse somatic cells requires BRCA1 but not the ATM kinase.	BRCA1 ATM	3.24e-05	3	115	2	23509290
Pubmed	Simultaneous ATM/BRCA1/RAD51 expression variations associated with prognostic factors in Iranian sporadic breast cancer patients.	BRCA1 ATM	3.24e-05	3	115	2	28058614
Pubmed	ATM-dependent activation of SIM2s regulates homologous recombination and epithelial-mesenchymal transition.	BRCA1 ATM	3.24e-05	3	115	2	30531838
Pubmed	The alymphoplasia (aly) mutation co-segregates with the intercellular adhesion molecule-2 (lcam-2) on mouse chromosome 11.	MAP3K14 CCL2	3.24e-05	3	115	2	7947467
Pubmed	Effect of PKC-β Signaling Pathway on Expression of MCP-1 and VCAM-1 in Different Cell Models in Response to Advanced Glycation End Products (AGEs).	CCL2 PRKCB	3.24e-05	3	115	2	26008233
Pubmed	Biochemical characterization of pKi67 with the identification of a mitotic-specific form associated with hyperphosphorylation and altered DNA binding.	MKI67 PRKCB	3.24e-05	3	115	2	10502411
Pubmed	Conductance and block of hair-cell mechanotransducer channels in transmembrane channel-like protein mutants.	TMC1 TMC3	3.24e-05	3	115	2	24981230
Pubmed	Mapping of genes controlling Leishmania major infection in CXS recombinant inbred mice.	B4GALNT2 CCL2	3.24e-05	3	115	2	9098403
Pubmed	The MHC class II molecule H2-M is targeted to an endosomal compartment by a tyrosine-based targeting motif.	HLA-DMA HLA-DMB	3.24e-05	3	115	2	7584146
Pubmed	BRCA1, Ki67, and β-Catenin Immunoexpression Is Not Related to Differentiation, Platinum Response, or Prognosis in Women With Low- and High-Grade Serous Ovarian Carcinoma.	BRCA1 MKI67	3.24e-05	3	115	2	29465506
Pubmed	IDO Regulates Macrophage Functions by Inhibiting the CCL2/CCR2 Signaling Pathway in Fungal Keratitis.	IDO1 CCL2	3.24e-05	3	115	2	37155343
Pubmed	Ki-67 and p53 expression of the fallopian tube mucosa in breast cancer patients with hereditary risk.	BRCA1 MKI67	3.24e-05	3	115	2	24196303
Pubmed	Screening for ATM sequence alterations in African-American women diagnosed with breast cancer.	BRCA1 ATM	3.24e-05	3	115	2	17333338
Pubmed	Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies.	HLA-DMA HLA-DMB	3.24e-05	3	115	2	12742663
Pubmed	Is olaparib cost effective in metastatic castration-resistant prostate cancer patients with at least one favorable gene mutation in BRCA1, BRCA2 or ATM?	BRCA1 ATM	3.24e-05	3	115	2	34517749
Cytoband	17q21	MAP3K14 BRCA1 RND2	5.45e-04	63	115	3	17q21
Cytoband	Ensembl 112 genes in cytogenetic band chr17q12	SLFN14 CCL2 CCL13 RPL19	5.57e-04	149	115	4	chr17q12
Cytoband	3q13.13	DZIP3 MYH15	8.25e-04	17	115	2	3q13.13
Cytoband	16q22.2	HP HYDIN	1.39e-03	22	115	2	16q22.2
Cytoband	5q35	ADAMTS12 CLTB	1.52e-03	23	115	2	5q35
Cytoband	9q21.13	TRPM6 GDA	1.80e-03	25	115	2	9q21.13
Cytoband	10q25.3	XPNPEP1 HABP2	2.42e-03	29	115	2	10q25.3
GeneFamily	Dyneins, axonemal	DNAH6 DNAH9 DNAH11	6.97e-05	17	87	3	536
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	BRCA1 MKI67 DZIP3 PPP1R36 HYDIN KNL1	2.39e-04	181	87	6	694
GeneFamily	Adhesion G protein-coupled receptors, subfamily G	ADGRG4 ADGRG6	4.73e-04	7	87	2	917
GeneFamily	Transmembrane channel likes	TMC1 TMC3	6.29e-04	8	87	2	1135
GeneFamily	Myosin heavy chains	MYH9 MYH15	2.31e-03	15	87	2	1098
GeneFamily	ADAM metallopeptidases with thrombospondin type 1 motif	ADAMTS12 ADAMTS16	3.71e-03	19	87	2	50
GeneFamily	Rho family GTPases	RND3 RND2	4.11e-03	20	87	2	390
Coexpression	GSE25087_FETAL_VS_ADULT_TREG_UP	CYBB MAP3K20 XPNPEP1 KIAA1586 GRK3 BRCA1 TOP1MT CTPS1 DNAH11	2.35e-07	198	115	9	M4641
Coexpression	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	CYBB HLA-DMA HLA-DMB PTPN1 CCL2 RND2 CTPS1	1.30e-05	176	115	7	MM1048
Coexpression	GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_UP	CYBB FLNB PPFIBP2 DGKH ADGRG6 PTPN1 DUSP16	1.67e-05	183	115	7	M7631
Coexpression	ZHANG_UTERUS_C5_MACROPHAGE	CYBB HEXB MRC1 HLA-DMA HLA-DMB FTH1 CCL2	1.92e-05	187	115	7	MM16611
Coexpression	MURARO_PANCREAS_ACINAR_CELL	FNIP2 USP53 MYH9 HLA-DMA MAP3K20 REG1A XPNPEP1 DUSP16 FTH1 CCL2 HSD17B4 GAREM1 RPL19	2.02e-05	732	115	13	M39174
Coexpression	GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_UP	CYBB IDO1 HLA-DMB PPFIBP2 RND3 CCL2 PRKCB	2.78e-05	198	115	7	M9704
Coexpression	ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	CYBB HLA-DMA HLA-DMB PTPN1 RND2 CTPS1	3.79e-05	141	115	6	M19618
Coexpression	HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL	FLNB NCAPD3 BRCA1 HP MKI67 MPHOSPH9 KNL1 MYBL2	4.33e-05	290	115	8	M45736
Coexpression	TABULA_MURIS_SENIS_LUNG_NON_CLASSICAL_MONOCYTE_AGEING	CYBB GDA HP FTH1	6.40e-05	49	115	4	MM3772
Coexpression	UROSEVIC_RESPONSE_TO_IMIQUIMOD	IDO1 OAS2 BRCA1	7.57e-05	19	115	3	M4857
Coexpression	DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS	SPATA17 ULK4 PPP1R36 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	8.08e-05	317	115	8	M40298
Coexpression	GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_UP	IL12RB2 IDO1 BRCA1 MSMO1 PIK3C3 MKI67 CCL13 MYBL2	9.40e-05	324	115	8	M41138
Coexpression	RUTELLA_RESPONSE_TO_HGF_UP	CYBB HEXB IDO1 SLC5A3 GRK3 FTH1 CCL2 CCL13 IL1R1	1.02e-04	421	115	9	M18149
Coexpression	HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST	NCAPD3 DCLRE1B KIAA1586 BRCA1 MKI67 MPHOSPH9 TOP1MT KNL1 MYBL2	1.69e-04	450	115	9	M45747
Coexpression	ZHANG_UTERUS_C12_MONOCYTE	CYBB HLA-DMA HLA-DMB PTPN1 GDA FTH1	1.85e-04	188	115	6	MM16618
Coexpression	GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS	DNAAF4 SPATA17 DZIP3 PPP1R36 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	1.96e-04	459	115	9	M39136
Coexpression	GSE10325_CD4_TCELL_VS_BCELL_DN	CYBB HLA-DMA HLA-DMB MAP3K14 CR2 PRKCB	2.26e-04	195	115	6	M3077
Coexpression	GSE28130_ACTIVATED_VS_INDUCEED_TREG_UP	NRDC MAP3K14 ADH7 GRK3 DZIP3 MYBL2	2.38e-04	197	115	6	M8343
Coexpression	GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_DN	CYBB HEXB GPRASP1 PPFIBP2 FTH1 CCL2	2.45e-04	198	115	6	M4606
Coexpression	GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN	TPP2 NRDC ARHGEF10L ZNF14 PRKCB CTPS1	2.52e-04	199	115	6	M4567
Coexpression	GSE17721_CTRL_VS_POLYIC_8H_BMDC_DN	ATP8B3 FLNC ADH7 RND3 DUSP16 CCL13	2.52e-04	199	115	6	M3718
Coexpression	GSE17721_POLYIC_VS_CPG_0.5H_BMDC_UP	WNT2B MAP3K14 CR2 HPGDS DUSP16 TOP1MT	2.52e-04	199	115	6	M3932
Coexpression	GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_UP	MRC1 HLA-DMB GRK3 PRKCB CCL13 IL1R1	2.58e-04	200	115	6	M4633
Coexpression	GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN	PIWIL1 MAP3K20 DCLRE1B CR2 BRCA1 MYBL2	2.58e-04	200	115	6	M8039
Coexpression	GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_UP	MRC1 ARHGEF10L GDA CLTB MKI67 ADGRL2	2.58e-04	200	115	6	M8085
Coexpression	GSE13306_RA_VS_UNTREATED_TCONV_DN	WWP1 PROKR2 FTH1 KCNS3 ADGRL2 DNAH6	2.58e-04	200	115	6	M3235
Coexpression	GSE28408_LY6G_POS_VS_NEG_DC_DN	HEXB NCAPD3 CTPS2 FTH1 PRKCB CTPS1	2.58e-04	200	115	6	M9545
Coexpression	GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN	IL12RB2 MAP3K14 OAS2 XPNPEP1 BRCA1 MYBL2	2.58e-04	200	115	6	M7162
Coexpression	GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	HLA-DMA DNAAF4 MAP3K20 SLC5A3 DUSP16 MKI67	2.58e-04	200	115	6	M7431
Coexpression	GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN	FLNB MYH9 HLA-DMA OAS2 ATM DNAH11	2.58e-04	200	115	6	M5068
Coexpression	GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_DN	IL12RB2 GRK3 BRCA1 MKI67 CTPS1 IL1R1	2.58e-04	200	115	6	M5292
Coexpression	GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP	MRC1 NCAPD3 MAP3K14 ADGRG6 CCL2 IL1R1	2.58e-04	200	115	6	M5241
Coexpression	HALLMARK_ALLOGRAFT_REJECTION	HLA-DMA HLA-DMB BRCA1 CCL2 PRKCB CCL13	2.58e-04	200	115	6	M5950
Coexpression	GSE3982_BASOPHIL_VS_TH2_UP	CYBB FLNB WWP1 CR2 HP CSAD	2.58e-04	200	115	6	M5566
Coexpression	GSE17721_0.5H_VS_8H_CPG_BMDC_UP	ITCH MRPL47 MAP3K14 PRKCB TOP1MT HSD17B4	2.58e-04	200	115	6	M4126
CoexpressionAtlas	Myeloid Cells, DC.4+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1	CYBB IL12RB2 FLNB HLA-DMA OAS2 ADGRG6 RND3 RGS18 GRK3 HPGDS DUSP16 PRKCB	1.03e-06	382	114	12	GSM538248_500
CoexpressionAtlas	Myeloid Cells, DC.4+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-1	CYBB IL12RB2 FLNB HLA-DMA OAS2 ADGRG6 RND3 RGS18 GRK3 HPGDS DUSP16 MKI67	1.06e-06	383	114	12	GSM605826_500
CoexpressionAtlas	Myeloid Cells, DC.103-11b+24+.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24+, Lung, avg-2	CYBB HEXB MRC1 HLA-DMA ADGRG6 RND3 GDA RGS18 GRK3 DUSP16 CCL2 IL1R1	1.84e-06	404	114	12	GSM854269_500
CoexpressionAtlas	Myeloid Cells, DC.103-11b+24-.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24-, Lung, avg-2	CYBB HEXB MRC1 HLA-DMA ADGRG6 RND3 GDA RGS18 GRK3 HPGDS DUSP16 CCL2	2.37e-06	414	114	12	GSM854271_500
CoexpressionAtlas	Myeloid Cells, MF.Lv, CD45+ F4/80+ CD11b+, Liver, avg-2	CYBB MRC1 HLA-DMA ARHGEF10L RND3 PTPN1 GDA RGS18 GRK3 HP CCL2	1.10e-05	402	114	11	GSM854320_500
CoexpressionAtlas	Myeloid Cells, DC.103-11b+F4/80lo.Kd, CD45+ CD11c+ I-A/I-E+ CD11b+ F4/80lo, Kidney, avg-3	CYBB HEXB MRC1 HLA-DMA OAS2 RND3 GDA RGS18 GRK3 HPGDS DUSP16	1.20e-05	406	114	11	GSM854273_500
CoexpressionAtlas	Myeloid Cells, DC.103+11b-.Lv, CD45+ CD11c+ MHC-II+ CD11b low CD103+, Liver, avg-2	CYBB FNIP2 MRC1 HLA-DMA PPFIBP2 RND3 RGS18 GRK3 DUSP16 MKI67 KNL1	1.29e-05	409	114	11	GSM538234_500
CoexpressionAtlas	Myeloid Cells, DC.8-.Th, CD11b-FITC CD4-PE MHCII-APC CD11c-eFluor780 CD8-eF, Thymus, avg-3	CYBB FNIP2 MRC1 HLA-DMA PPFIBP2 RND3 RGS18 GRK3 HPGDS MKI67 KNL1	1.41e-05	413	114	11	GSM605831_500
CoexpressionAtlas	B cells, MLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R-, Bone marrow, avg-2	MAP3K20 GDA RGS18 GRK3 BRCA1 HP MKI67 ADGRL2 IL1R1 KNL1 MYBL2	1.72e-05	422	114	11	GSM791124_500
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#1_top-relative-expression-ranked_1000	USP53 PPFIBP2 KCNH1 DUSP16 ADAMTS16 PRKCB RND2	2.15e-05	156	114	7	gudmap_dev gonad_e11.5_M_GonMes_Sma_k1_1000
CoexpressionAtlas	Myeloid Cells, MF.Medl.SLN, CD11b+ CD169+ F4/80+, Lymph Node, avg-2	CYBB MRC1 OAS2 RND3 PTPN1 GDA RGS18 GRK3 HP CCL2	4.96e-05	391	114	10	GSM854322_500
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-1	CYBB IL12RB2 FLNB HLA-DMA ADGRG6 RND3 RGS18 GRK3 DUSP16 MKI67	5.41e-05	395	114	10	GSM538265_500
CoexpressionAtlas	B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1	CYBB GDA RGS18 HP IL1R1	6.71e-05	79	114	5	GSM538343_100
CoexpressionAtlas	Myeloid Cells, Mo.6C+II+.Bl, CD115+ B220- CD43+ Ly6C+ MHCIIint, Blood, avg-4	CYBB MRC1 HLA-DMA OAS2 ARHGEF10L RND3 GDA RGS18 GRK3 HP	7.08e-05	408	114	10	GSM605868_500
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b-.Sp, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Spleen, avg-2	CYBB HLA-DMA RND3 RGS18 GRK3	7.12e-05	80	114	5	GSM605837_100
CoexpressionAtlas	Myeloid Cells, DC.103-11b+.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3	CYBB MRC1 HLA-DMA ADGRG6 RND3 GDA RGS18 GRK3 DUSP16 CCL2	7.22e-05	409	114	10	GSM605823_500
CoexpressionAtlas	kidney_adult_RenalCapsule_top-relative-expression-ranked_1000	CYBB HEXB USP53 MRC1 MYH9 HLA-DMA DNAAF4 PPFIBP2 WNT2B ADGRG6 CLTB CCL2 PLEKHH2 IL1R1	7.36e-05	778	114	14	gudmap_kidney_adult_RenalCapsule_1000
CoexpressionAtlas	dev gonad_e13.5_M_SertoliCell_Sox9_k-means-cluster#2_top-relative-expression-ranked_200	PPFIBP2 KCNH1 ADAMTS16 RND2	1.39e-04	49	114	4	gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_k2_200
CoexpressionAtlas	Myeloid Cells, DC.11cloSer.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-lo CD11b+, Small Intestine, avg-4	CYBB MRC1 HLA-DMA OAS2 GDA GRK3 HPGDS DUSP16 CCL2	1.54e-04	364	114	9	GSM854276_500
CoexpressionAtlas	Myeloid Cells, DC.LC.Sk, MHCII+ CD11b+ CD45+, Skin, avg-2	HLA-DMA PPFIBP2 DGKH ADGRG6 RND3 RGS18 GRK3 HPGDS DUSP16 ADGRL2	1.61e-04	451	114	10	GSM538280_500
CoexpressionAtlas	B cells, B.Pl.AA4+220-.BM, CD138+ AA4.1+ CD43- CD45R-, Bone marrow, avg-3	CYBB GDA RGS18 HP	1.62e-04	51	114	4	GSM777027_100
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000	USP53 FLNC PPFIBP2 ADAMTS12 RND3 BRCA1 PROKR2 KCNH1 ZNF655 DUSP16 ADAMTS16 PRKCB RND2 PLEKHH2	1.84e-04	849	114	14	gudmap_dev gonad_e11.5_M_GonMes_Sma_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_1000	PPFIBP2 KCNH1 ADAMTS16 PRKCB RND2 PPP1R36	1.91e-04	155	114	6	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k1_1000
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-2	CYBB IL12RB2 HLA-DMA ADGRG6 RND3 RGS18 GRK3 DUSP16 MKI67	1.97e-04	376	114	9	GSM538266_500
CoexpressionAtlas	Myeloid Cells, MF.169+11chi.SLN, CD11b+ CD169+ CD11chigh, Lymph Node, avg-2	CYBB FNIP2 MRC1 HLA-DMA ADGRG6 RND3 GDA RGS18 GRK3	2.34e-04	385	114	9	GSM854315_500
CoexpressionAtlas	Myeloid Cells, DC.4+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-3	CYBB IL12RB2 HLA-DMA OAS2 ADGRG6 RND3 RGS18 GRK3 DUSP16	2.63e-04	391	114	9	GSM538249_500
CoexpressionAtlas	B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2	CYBB MAP3K20 GDA RGS18 BRCA1 HP MKI67 IL1R1 KNL1	3.05e-04	399	114	9	GSM538345_500
CoexpressionAtlas	Stem Cells, SC.CDP.BM, Sca1- Flt3+ MCSFR+ cKitlo, Bone marrow, avg-3	CYBB HLA-DMA RND3 RGS18 GRK3 BRCA1 HP MKI67 KNL1	3.16e-04	401	114	9	GSM791114_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	FLNC PPFIBP2 TMC3 RND3 PROKR2 KCNH1 ADAMTS16 PRKCB RND2 PLEKHH2 PPP1R36 IL1R1 KNL1	3.34e-04	793	114	13	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	Stromal Cells, Ep.MEChi.Th, CD45-EpCAm+Ly51-MHCIIhi, Thymus, avg-1	CYBB FLNB ADGRG6 RND3 GDA PROKR2 DUSP16 ADGRL2 IL1R1	3.78e-04	411	114	9	GSM854302_500
CoexpressionAtlas	Myeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3	CYBB FNIP2 MRC1 HLA-DMA RND3 GDA GRK3 CCL2 ADGRL2	3.78e-04	411	114	9	GSM538239_500
CoexpressionAtlas	Myeloid Cells, DC.8+.Th, CD11b-FITC CD4-PE MHCII-APC CD11c-eFluor780 CD8-eF, Thymus, avg-3	FNIP2 MRC1 HLA-DMA PPFIBP2 RND3 RGS18 GRK3 MKI67 KNL1	3.85e-04	412	114	9	GSM605828_500
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	USP53 TDRD5 ITCH SLC5A3 BRCA1 PROKR2 KCNH1 ADAMTS16 DZIP3 ZNF616 RND2 KNL1 MYBL2	3.90e-04	806	114	13	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_200	PPFIBP2 KCNH1 CLTB ADAMTS16 RND2 PPP1R36	3.91e-04	177	114	6	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_200
CoexpressionAtlas	Myeloid Cells, MF.Medl.SLN, CD11b+ CD169+ F4/80+, Lymph Node, avg-2	CYBB MRC1 GDA HP	3.91e-04	64	114	4	GSM854322_100
CoexpressionAtlas	Myeloid Cells, Mo.6C-II+.Bl, CD115+ B220- CD43+ Ly6C- MHCIIhi, Blood, avg-2	CYBB MRC1 HLA-DMA OAS2 RND3 GDA RGS18 GRK3 HP	3.92e-04	413	114	9	GSM605878_500
CoexpressionAtlas	dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_1000	USP53 GPRASP1 PPFIBP2 ADAMTS16 RND2	3.92e-04	115	114	5	gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k4_1000
CoexpressionAtlas	Myeloid Cells, GN.Thio.PC, CD11b+ Ly6-G+, Peritoneal Cavity, avg-3	CYBB FNIP2 DNAAF4 OAS2 PTPN1 GDA RGS18 HP DUSP16	4.13e-04	416	114	9	GSM854309_500
CoexpressionAtlas	Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2	CYBB GPRASP1 GDA RGS18 GRK3 HP MKI67 ADGRL2 KNL1	4.58e-04	422	114	9	GSM399442_500
CoexpressionAtlas	Myeloid Cells, Mo.6C-IIint.Bl, CD115+ B220- CD43- Ly6C- MHCIIint, Blood, avg-5	CYBB GDA GRK3 DUSP16	4.65e-04	67	114	4	GSM605886_100
CoexpressionAtlas	Stem Cells, SC.STSL.BM, CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Bone marrow, avg-3	CYBB GPRASP1 CUL7 GDA RGS18 GRK3 HP ADGRL2 IL1R1	4.66e-04	423	114	9	GSM399454_500
CoexpressionAtlas	Myeloid Cells, DC.103+11b-.Lu, CD11chi CD11b low CD103+ MHCII+ SiglecF-, Lung, avg-3	CYBB FNIP2 MRC1 HLA-DMA PPFIBP2 RND3 RGS18 GRK3 MKI67	4.74e-04	424	114	9	GSM538231_500
CoexpressionAtlas	Myeloid Cells, Mo.6C+II-.LN, F480+ Ly6c+ MHCII lo/+, Lymph Node, avg-3	CYBB GDA GRK3 HP	4.92e-04	68	114	4	GSM605875_100
CoexpressionAtlas	Myeloid Cells, GN.BM, CD11b+ Ly6-G+, Bone marrow, avg-4	CYBB GDA RGS18 HP	5.50e-04	70	114	4	GSM605846_100
CoexpressionAtlas	B cells, proB.CLP.BM, AA4.1+ CD117+ IL7R+ CD45R- CD24- CD19- IgM-, Bone marrow, avg-1	CYBB GDA RGS18 HP	5.50e-04	70	114	4	GSM538347_100
CoexpressionAtlas	Myeloid Cells, Mo.6C-II-.Bl, CD115+ B220- CD43- Ly6C- MHCII-, Blood, avg-3	CYBB GDA GRK3 DUSP16	5.50e-04	70	114	4	GSM605883_100
CoexpressionAtlas	kidney_adult_RenCorpuscGlomer_k-means-cluster#4_top-relative-expression-ranked_100	TDRD5 MYOM2 TOP1MT	5.51e-04	30	114	3	gudmap_kidney_adult_RenCorpuscGlomer_k4_100
CoexpressionAtlas	Myeloid Cells, MF.Thio5.II+480int.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3	CYBB FNIP2 MRC1 HLA-DMA WWP1 ADGRG6 GDA RGS18 HPGDS	5.51e-04	433	114	9	GSM605856_500
CoexpressionAtlas	Myeloid Cells, Mo.6C-II+.Bl, CD115+ B220- CD43+ Ly6C- MHCIIhi, Blood, avg-2	CYBB HLA-DMA RND3 GRK3	5.80e-04	71	114	4	GSM605878_100
CoexpressionAtlas	Myeloid Cells, GN.Arth.BM, CD11b+ Ly6-G+, Bone marrow, avg-3	CYBB GDA RGS18 HP	5.80e-04	71	114	4	GSM854303_100
CoexpressionAtlas	dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#2_top-relative-expression-ranked_1000	USP53 PPFIBP2 KCNH1 DUSP16 PRKCB	5.95e-04	126	114	5	gudmap_dev gonad_e11.5_F_GonMes_Sma_k2_1000
CoexpressionAtlas	Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3	CYBB FNIP2 MRC1 FLNB WWP1 ADGRG6 GDA RGS18 HPGDS	6.28e-04	441	114	9	GSM605862_500
CoexpressionAtlas	B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R+ CD117+ IL7R+, Bone marrow, avg-1	CYBB GDA RGS18 HP	6.45e-04	73	114	4	GSM538351_100
CoexpressionAtlas	Myeloid Cells, DC.103-11b+F4/80lo.Kd, CD45+ CD11c+ I-A/I-E+ CD11b+ F4/80lo, Kidney, avg-3	CYBB MRC1 RND3 GRK3	6.45e-04	73	114	4	GSM854273_100
CoexpressionAtlas	kidney_adult_Podocyte_MafB_top-relative-expression-ranked_500	TDRD5 DNAAF4 PPFIBP2 MAP3K20 SLC5A3 CLTB MYOM2 TOP1MT PLEKHH2	6.69e-04	445	114	9	gudmap_kidney_adult_Podocyte_MafB_500
CoexpressionAtlas	B cells, B.Pl.AA4-.BM, CD138+ AA4.1- CD43+, Bone marrow, avg-2	CYBB GDA RGS18 HP	6.79e-04	74	114	4	GSM777030_100
CoexpressionAtlas	Myeloid Cells, DC.4+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-1	CYBB RND3 RGS18 GRK3	7.14e-04	75	114	4	GSM605826_100
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b-.Sp, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Spleen, avg-1	CYBB RND3 RGS18 GRK3	7.89e-04	77	114	4	GSM605839_100
CoexpressionAtlas	kidney_adult_RenalCapsule_k-means-cluster#4_top-relative-expression-ranked_1000	MRC1 MYH9 ADGRG6 PLEKHH2 IL1R1	8.41e-04	136	114	5	gudmap_kidney_adult_RenalCapsule_k4_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	FLNC PPFIBP2 TMC3 RND3 PROKR2 KCNH1 ADAMTS16 DZIP3 RND2 PLEKHH2 PPP1R36 ADGRL2	8.70e-04	768	114	12	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlas	dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000	USP53 GPRASP1 NRDC PPFIBP2 BRCA1 KCNH1 DUSP16 CLTB ADAMTS16 PRKCB RND2 PPP1R36 ADGRL2	8.85e-04	880	114	13	gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000
CoexpressionAtlas	Myeloid Cells, DC.103+11b-.SI, CD45+ MHCII+ CD11c-hi CD103+ CD11b-, Small Intestine, avg-4	CYBB FNIP2 HLA-DMA PPFIBP2 RND3 GRK3 HPGDS DUSP16	9.03e-04	372	114	8	GSM854251_500
CoexpressionAtlas	Myeloid Cells, MF.Thio5.II+480int.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3	CYBB MRC1 GDA HPGDS	9.10e-04	80	114	4	GSM605856_100
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500	FLNC PPFIBP2 TMC3 RND3 PROKR2 ADAMTS16 PLEKHH2 PPP1R36	9.19e-04	373	114	8	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500
CoexpressionAtlas	Myeloid Cells, Mo.6C+II-.LN, F480+ Ly6c+ MHCII lo/+, Lymph Node, avg-3	CYBB HLA-DMA OAS2 ARHGEF10L RND3 GDA GRK3 HP	9.35e-04	374	114	8	GSM605875_500
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b-.Sp, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Spleen, avg-2	CYBB IL12RB2 HLA-DMA RND3 RGS18 GRK3 DUSP16 MKI67	9.51e-04	375	114	8	GSM605837_500
CoexpressionAtlas	Myeloid Cells, MF.Thio5.II-480int.PC, CD115+ MHCII- F480int SiglecF- CD11c+, Peritoneal Cavity, avg-3	CYBB MRC1 GDA HPGDS	9.54e-04	81	114	4	GSM605865_100
CoexpressionAtlas	Myeloid Cells, DC.4+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3	CYBB ADGRG6 RND3 GRK3	9.99e-04	82	114	4	GSM538242_100
CoexpressionAtlas	dev gonad_e13.5_M_SertoliCell_Sox9_k-means-cluster#4_top-relative-expression-ranked_1000	USP53 NRDC PPFIBP2 KCNH1 DUSP16 CLTB ADAMTS16 RND2 PPP1R36	1.04e-03	474	114	9	gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_k4_1000
CoexpressionAtlas	Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1	CYBB GDA RGS18 ADGRL2	1.04e-03	83	114	4	GSM476663_100
CoexpressionAtlas	B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2	CYBB GDA RGS18 BRCA1 HP MKI67 KNL1 MYBL2	1.18e-03	388	114	8	GSM538352_500
CoexpressionAtlas	kidney_adult_RenCorpuscGlomer_top-relative-expression-ranked_100	TDRD5 MRC1 MYOM2 TOP1MT	1.19e-03	86	114	4	gudmap_kidney_adult_RenCorpuscGlomer_100
CoexpressionAtlas	B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2	CYBB RGS18 MKI67 KNL1	1.35e-03	89	114	4	GSM538352_100
CoexpressionAtlas	Myeloid Cells, DC.4+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3	CYBB HLA-DMA ADGRG6 RND3 RGS18 GRK3 DUSP16 PRKCB	1.43e-03	400	114	8	GSM538242_500
CoexpressionAtlas	Stem Cells, SC.MPP34F.BM, Lineage- cKit+ Sca-1+ flk2+ CD34+, Bone marrow, avg-2	GPRASP1 MAP3K20 RGS18 BRCA1 MKI67 ADGRL2 IL1R1 KNL1	1.46e-03	401	114	8	GSM791110_500
CoexpressionAtlas	Myeloid Cells, DC.103+11b-.Lu, MHCII+ CD11c+ CD103+ CD11b, Lung, avg-2	FNIP2 HLA-DMA PPFIBP2 RND3 RGS18 GRK3 DUSP16 MKI67	1.48e-03	402	114	8	GSM854241_500
CoexpressionAtlas	Myeloid Cells, Mo.6C-II-.Bl, CD115+ B220- CD43- Ly6C- MHCII-, Blood, avg-3	CYBB MAP3K14 DGKH ARHGEF10L GDA GRK3 HP DUSP16	1.48e-03	402	114	8	GSM605883_500
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500	USP53 ITCH SLC5A3 PROKR2 ADAMTS16 DZIP3 ZNF616 RND2	1.50e-03	403	114	8	gudmap_developingGonad_e12.5_epididymis_500
CoexpressionAtlas	B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1	CYBB GDA RGS18 BRCA1 HP MKI67 IL1R1 KNL1	1.55e-03	405	114	8	GSM538343_500
CoexpressionAtlas	Myeloid Cells, DC.4+.SLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3	CYBB MRC1 HLA-DMA ADGRG6 RND3 GDA RGS18 GRK3	1.60e-03	407	114	8	GSM538245_500
CoexpressionAtlas	Stem Cells, SC.CMP.BM, Lineage- Kit+ Sca1- CD34+ FcgRlow, Bone marrow, avg-2	MAP3K20 RGS18 GRK3 BRCA1 MKI67 ADGRL2 KNL1	1.63e-03	317	114	7	GSM791117_500
CoexpressionAtlas	Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2	GPRASP1 CUL7 RGS18 BRCA1 MKI67 DZIP3 ADGRL2 KNL1	1.67e-03	410	114	8	GSM791122_500
CoexpressionAtlas	Myeloid Cells, Mo.6C+II-.Bl, Cd115+ B220- CD43+ Ly6C+ MHCII-, Blood, avg-3	CYBB FNIP2 OAS2 RND3 GDA RGS18 GRK3 HP	1.70e-03	411	114	8	GSM605872_500
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b-.Sp, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Spleen, avg-1	CYBB IL12RB2 HLA-DMA PPFIBP2 RND3 RGS18 GRK3 DUSP16	1.73e-03	412	114	8	GSM605839_500
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b+.MLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-2	CYBB IDO1 PPFIBP2 MAP3K14 ADGRG6 RND3 GRK3 DUSP16	1.75e-03	413	114	8	GSM538263_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3	HLA-DMA MRPL47 PPFIBP2 ADGRG6 CTPS2 CLTB MKI67 DZIP3 CCL2 MPHOSPH9 IL1R1 KNL1	1.75e-03	834	114	12	Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-1	CYBB IDO1 PPFIBP2 MAP3K14 ADGRG6 RND3 GRK3 DUSP16	1.78e-03	414	114	8	GSM538262_500
CoexpressionAtlas	Myeloid Cells, GN.BM, CD11b+ Ly6-G+, Bone marrow, avg-4	CYBB DNAAF4 OAS2 DGKH GDA RGS18 HP DNAH6	1.81e-03	415	114	8	GSM605846_500
CoexpressionAtlas	kidney_adult_Podocyte_MafB_top-relative-expression-ranked_1000	TDRD5 MYH9 NRDC DNAAF4 PPFIBP2 MAP3K20 DGKH SLC5A3 CLTB MYOM2 TOP1MT PLEKHH2	1.82e-03	838	114	12	gudmap_kidney_adult_Podocyte_MafB_1000
CoexpressionAtlas	dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_500	KCNH1 ADAMTS16 RND2 PPP1R36	1.86e-03	97	114	4	gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k1_500
CoexpressionAtlas	Myeloid Cells, DC.8+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3	FNIP2 HLA-DMA PPFIBP2 RND3 RGS18 GRK3 DUSP16 MKI67	1.95e-03	420	114	8	GSM538252_500
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAAF4 SPATA17 DZIP3 ULK4 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	2.03e-09	194	115	9	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAAF4 SPATA17 DZIP3 PPP1R36 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	2.12e-09	195	115	9	649fd2336e963f6a150d182a53ad5dd838ca80b1
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAAF4 SPATA17 DZIP3 PPP1R36 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	2.12e-09	195	115	9	129ad5f4253ecb1a8477cc38773e6e91ea9570b0
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAAF4 SPATA17 DZIP3 PPP1R36 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	2.12e-09	195	115	9	3e70ee987d66d450062d5df3d7c733ccc7344470
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-conventional_dendritic_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FNIP2 HEXB MRC1 HLA-DMA IDO1 HLA-DMB MAP3K20 ADGRG6 RGS18	2.43e-09	198	115	9	42be18aef4f656a86c61630b061826a858c496fd
ToppCell	Severe_COVID-19-Myeloid-MoAM4\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	CYBB FNIP2 HEXB MRC1 HLA-DMA FTH1 CCL2 CCL13 HSD17B4	2.65e-09	200	115	9	30448a41ca64d6f0fedaff0b7a6670dd33cdf2c5
ToppCell	BAL-Severe-Myeloid-MoAM-MoAM4-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CYBB FNIP2 HEXB MRC1 HLA-DMA FTH1 CCL2 CCL13 HSD17B4	2.65e-09	200	115	9	4f481d87e30195365900acb5d50641a9e7b2f462
ToppCell	BAL-Severe-Myeloid-MoAM-MoAM4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CYBB FNIP2 HEXB MRC1 HLA-DMA FTH1 CCL2 CCL13 HSD17B4	2.65e-09	200	115	9	cf720d3973e79ffd4c6e763a7284799ced22a274
ToppCell	BAL-Severe-Myeloid-MoAM-MoAM4-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CYBB FNIP2 HEXB MRC1 HLA-DMA FTH1 CCL2 CCL13 HSD17B4	2.65e-09	200	115	9	5490393c5f54748f912676e19b58bd1320415a06
ToppCell	BAL-Severe-Myeloid-MoAM-MoAM4\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CYBB FNIP2 HEXB MRC1 HLA-DMA FTH1 CCL2 CCL13 HSD17B4	2.65e-09	200	115	9	df821ac12953e44fcfedbbefb35a4976e406ccd6
ToppCell	droplet-Kidney-nan-3m-Myeloid-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB HEXB MRC1 HLA-DMA GRK3 HPGDS B4GALNT2 CCL2	8.75e-09	159	115	8	bea6e96ba40ebfc1e38687bfa1c61fe227c5a84d
ToppCell	facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB MAP3K14 ARHGEF10L GDA GRK3 DUSP16 MKI67 PRKCB	9.19e-09	160	115	8	bc4a93dc5f37829799c37877e751ff3bc122e4ab
ToppCell	droplet-Trachea-3m-Hematologic-myeloid-granulocyte-\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB MRC1 OAS2 BRCA1 HPGDS MKI67 CCL2 PRKCB	1.55e-08	171	115	8	41932c9e70829ee3d55ca5fdb74d290fc8229416
ToppCell	facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DNAAF4 SPATA17 PPP1R36 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	2.21e-08	179	115	8	8a66d197a2f55d763ff7ef0bec89ee96f59c3937
ToppCell	facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DNAAF4 SPATA17 PPP1R36 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	2.21e-08	179	115	8	d4efbc34f52136039b96451fd0b0a0ad164197c6
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRG6 RND3 SPATA17 ADAMTS16 PLEKHH2 DNAH6 HYDIN DNAH11	2.98e-08	186	115	8	5c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAAF4 SPATA17 DZIP3 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	2.98e-08	186	115	8	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|368C / Donor, Lineage, Cell class and subclass (all cells)	CYBB MRC1 HLA-DMA HLA-DMB RGS18 HPGDS CCL2 CCL13	3.51e-08	190	115	8	cbba3d94a4c3e0b0d14f3b7c60dba5d6e097c5e3
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYBB FNIP2 HEXB MRC1 HLA-DMB KBTBD8 ADGRG4 CCL2	3.65e-08	191	115	8	51535232e889db52a9b24e5696b1687e93dd7302
ToppCell	tumor_Lung-Myeloid_cells-Alveolar_Mac\|tumor_Lung / Location, Cell class and cell subclass	CYBB HEXB MRC1 HLA-DMA HLA-DMB RND3 HP FTH1	3.81e-08	192	115	8	44eda67501e69799c5981be602c143d12f5f222f
ToppCell	Bronchial_Biopsy-Epithelial-Ciliated_1\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	DNAAF4 SPATA17 DZIP3 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	3.81e-08	192	115	8	be592e661367affced9ebe80849b466e6adb3a34
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	SPATA17 DZIP3 ULK4 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	3.96e-08	193	115	8	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAAF4 SPATA17 DZIP3 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	3.96e-08	193	115	8	e1b76102f812c433195d1e8811fdd3293a7bc22e
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	SPATA17 DZIP3 ULK4 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	3.96e-08	193	115	8	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	Bronchial_Biopsy-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	DNAAF4 SPATA17 DZIP3 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	3.96e-08	193	115	8	0b62a6ddd7c42efd9f39781971d1438501e1fa8d
ToppCell	Bronchial_Brush-Epithelial-Ciliated_1\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	DNAAF4 SPATA17 DZIP3 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	4.12e-08	194	115	8	b4ce60c06568123008b1081d644733cb91c28f51
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ADGRG6 ADAMTS12 RND3 GRK3 PRKCB PLEKHH2 ADGRL2 IL1R1	4.12e-08	194	115	8	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	Bronchial_Brush-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	DNAAF4 SPATA17 DZIP3 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	4.12e-08	194	115	8	7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IDO1 DNAAF4 SPATA17 DZIP3 PPP1R36 DTHD1 HYDIN DNAH11	4.29e-08	195	115	8	d211a836cf711fdb91b10d512f09d462be937cc5
ToppCell	(010)_cDC\|World / immune cells in Peripheral Blood (logTPM normalization)	FNIP2 MRC1 HLA-DMA IDO1 HLA-DMB MAP3K20 ADGRG6 RGS18	4.29e-08	195	115	8	4aabb3f5ce70100e4d98d7fa9f8d12e84fb9fe3d
ToppCell	NS-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAAF4 ADH7 SPATA17 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	4.29e-08	195	115	8	34e37cff4849696ca4ba5dd8fd2cf98fed8bc912
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAAF4 SPATA17 DZIP3 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	4.29e-08	195	115	8	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-conventional_dendritic_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYBB FNIP2 MRC1 HLA-DMA HLA-DMB KBTBD8 PTPN1 RPL19	4.29e-08	195	115	8	a65441ab3ee1949ec14db1d2d03bb1ee80d389bd
ToppCell	390C-Myeloid-Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CYBB HEXB MRC1 HLA-DMA HLA-DMB DNAAF4 ARHGEF10L RND3	4.29e-08	195	115	8	ba494be431916d43c1d480f65bed674c0722c710
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ADGRG6 ADAMTS12 RND3 GRK3 PRKCB PLEKHH2 ADGRL2 IL1R1	4.29e-08	195	115	8	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	(3)_MNP-(3)_Macrophage_MARCOneg\|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)	MRC1 HLA-DMA HLA-DMB WWP1 ADGRG6 HPGDS CCL2 CCL13	4.29e-08	195	115	8	e4b5e4b8832669fb4d1661ecd828b81e621d35c4
ToppCell	critical-Epithelial-Ciliated\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAAF4 SPATA17 DZIP3 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	4.46e-08	196	115	8	27b855c6e1ae44f16db998cf0e81bd686b9cee7e
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYBB FNIP2 HEXB MRC1 HLA-DMA HLA-DMB KBTBD8 CCL2	4.46e-08	196	115	8	7ce416e1809bfbb39553c28c20125790100a938d
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYBB FNIP2 HEXB MRC1 HLA-DMA HLA-DMB KBTBD8 CCL2	4.46e-08	196	115	8	292da8a0c052917a2f68afee9068b5b8e1544b13
ToppCell	PSB-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAAF4 SPATA17 DZIP3 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	4.64e-08	197	115	8	6865f4831eb23794fb88a8649d48d497bbae3f44
ToppCell	VE-mDC2-\|VE / Condition, Cell_class and T cell subcluster	CYBB MRC1 HLA-DMA IDO1 HLA-DMB RGS18 GRK3 HPGDS	4.64e-08	197	115	8	6629588819ec31a7e4f33b94b8c035145a5f6c17
ToppCell	mild_COVID-19-cDC\|mild_COVID-19 / disease group, cell group and cell class (v2)	FNIP2 HEXB MRC1 HLA-DMA IDO1 HLA-DMB ADGRG6 TOP1MT	4.64e-08	197	115	8	44ebd3f967779bb7753fc6dcd9fde6d682f9ccd6
ToppCell	VE-mDC2\|VE / Condition, Cell_class and T cell subcluster	CYBB MRC1 HLA-DMA IDO1 HLA-DMB RGS18 GRK3 HPGDS	4.64e-08	197	115	8	e3172102ad17c92c3038cad37bf933eb04351048
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-B_cells-Memory_B\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYBB HLA-DMA HLA-DMB CR2 PTPN1 GRK3 PRKCB RPL19	4.64e-08	197	115	8	5b172bc2f3f6bd4741600e1ea299c469685eba4f
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADH7 DZIP3 PPP1R36 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	4.64e-08	197	115	8	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADH7 DZIP3 PPP1R36 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	4.64e-08	197	115	8	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADH7 DZIP3 PPP1R36 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	4.64e-08	197	115	8	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	control-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAAF4 SPATA17 DZIP3 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	4.64e-08	197	115	8	e453d085182364ca347cbcc9dc995c62c3353016
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADH7 DZIP3 PPP1R36 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	4.64e-08	197	115	8	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	control-Epithelial-Ciliated\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAAF4 SPATA17 DZIP3 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	4.64e-08	197	115	8	d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FNIP2 HEXB MRC1 HLA-DMA HLA-DMB MAP3K20 ADGRG6 RGS18	4.83e-08	198	115	8	898ef4f02443780f9b1fc08b73a165fda0ca5cde
ToppCell	critical-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAAF4 SPATA17 DZIP3 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	4.83e-08	198	115	8	ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40
ToppCell	367C-Myeloid-Macrophage-SPP1+_Macrophage\|367C / Donor, Lineage, Cell class and subclass (all cells)	CYBB HEXB MRC1 HLA-DMA HLA-DMB FTH1 CCL2 CCL13	4.83e-08	198	115	8	1771c282cd6422c35a4131c827d7daedfd6e7541
ToppCell	tumor_Lung-Myeloid_cells-mo-Mac\|tumor_Lung / Location, Cell class and cell subclass	CYBB HEXB MRC1 HLA-DMA HLA-DMB FTH1 CCL2 CCL13	5.02e-08	199	115	8	77d46acf655029eab23471dc4c4a1b0832b24306
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CYBB MRC1 HLA-DMA HLA-DMB HPGDS MKI67 CCL2 CCL13	5.02e-08	199	115	8	ca0f6526ba0dcf8789dd3b583291519626427f2f
ToppCell	ILEUM-inflamed-(8)_Fibroblasts\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FLNB WNT2B RND3 CCL2 KCNS3 CCL13 PLEKHH2 ADGRL2	5.02e-08	199	115	8	3a3e2bb21cd0293622b1a975263e918d9ba24265
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYBB MRC1 HLA-DMA HLA-DMB WWP1 RGS18 GRK3 HPGDS	5.02e-08	199	115	8	f34c15df58fbdc6c90e30800e26fabbf828ad10b
ToppCell	ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FLNB IDO1 RND3 CCL2 CCL13 PLEKHH2 ADGRL2 IL1R1	5.02e-08	199	115	8	56d72da6a5fab9cbb2975fe6f87a631debaba6a8
ToppCell	COVID-19-Myeloid-MoAM2,_CCL18\|COVID-19 / Condition, Lineage and Cell class	CYBB FNIP2 HEXB MRC1 HLA-DMA FTH1 CCL2 CCL13	5.22e-08	200	115	8	b0a50622d00335843efad86bc56a1e910019984b
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MRC1 OAS2 BRCA1 HPGDS MKI67 CCL2 KNL1	8.86e-08	142	115	7	be63c48794a227ea55978524c0f5935342fc455e
ToppCell	facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB MRC1 ADGRG6 GDA RGS18 HP MKI67	1.48e-07	153	115	7	0ef7c45cdd854c79e527006034029767f8e108b2
ToppCell	facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB ARHGEF10L GDA GRK3 DUSP16 MKI67 PRKCB	1.84e-07	158	115	7	121d63b8e2e37107467b170e5b2c798a7dbf6325
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HEXB TPP2 MRC1 KBTBD8 HPGDS CCL2 KNL1	1.92e-07	159	115	7	c0e55f25271f788c08fa4b95186501fc27b2ec39
ToppCell	facs-Lung-Endomucin-24m-Myeloid\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB PTPN1 GDA GRK3 HP DUSP16 FTH1	1.92e-07	159	115	7	886cbaef39a3517514a3896b6b960d01a3af043d
ToppCell	facs-Lung-ENDOMUCIN-18m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB MAP3K14 ARHGEF10L GRK3 DUSP16 MKI67 PRKCB	2.00e-07	160	115	7	2020b6defbaf5b5db12af37f0103ac028a8ca76e
ToppCell	facs-Lung-ENDOMUCIN-18m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB MAP3K14 ARHGEF10L GRK3 DUSP16 MKI67 PRKCB	2.00e-07	160	115	7	af7cf0dc5fe7c02f7d6c436f6dde766c79ff0eae
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYBB HEXB MRC1 WWP1 ARHGEF10L HPGDS CCL2	2.09e-07	161	115	7	8937f6b92cb2a93ea8c4780d9200a518c3112e53
ToppCell	LPS-antiTNF-Endothelial-Endothelial-FOXM1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NCAPD3 PIWIL1 BRCA1 MKI67 MPHOSPH9 KNL1 MYBL2	2.27e-07	163	115	7	5285318c52aa31c9b22dc2ffff078e32e408604d
ToppCell	facs-Lung-EPCAM-24m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB ARHGEF10L GDA GRK3 HP DUSP16 PRKCB	2.37e-07	164	115	7	15d52666e5150e7c34b1f641a937fb2d5e8aaf8a
ToppCell	facs-Lung-EPCAM-24m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB ARHGEF10L GDA GRK3 HP DUSP16 PRKCB	2.37e-07	164	115	7	d622f0d8d8bad48dfdf160ec63c545df192637a9
ToppCell	Dendritic_Cells-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	IDO1 PIWIL1 RGS18 MKI67 CCL13 KNL1	2.40e-07	100	115	6	bb7bd11e28be830f381144d4a6f29a86da59d9fa
ToppCell	droplet-Lung-nan-18m-Myeloid-Intermediate_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB ITCH HLA-DMA ARHGEF10L GDA GRK3 DUSP16	2.47e-07	165	115	7	0fbdd043e11aa8dbff4cd3a4da1b2feb49878a09
ToppCell	droplet-Lung-nan-18m-Myeloid-intermediate_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB ITCH HLA-DMA ARHGEF10L GDA GRK3 DUSP16	2.47e-07	165	115	7	e32697321cef424c2ad4e11ee9da3e510d5ce505
ToppCell	facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB ARHGEF10L GDA GRK3 HP DUSP16 PRKCB	2.79e-07	168	115	7	c0aef5947b1d7e2c81a7481c509feda1687fcd7f
ToppCell	facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB ARHGEF10L GDA GRK3 HP DUSP16 PRKCB	2.79e-07	168	115	7	c861f80aa12caf54a94d93e38539ff41dc5227a6
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HEXB FLNB HLA-DMA RND3 RGS18 GRK3 GUCY2C	2.79e-07	168	115	7	2c996d09b6a8ccd3c708146eca310b02eafff425
ToppCell	droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB MAP3K14 ARHGEF10L GDA GRK3 DUSP16 PRKCB	2.79e-07	168	115	7	689c41f6e9f65381570991cc311cba49a57ec955
ToppCell	droplet-Lung-nan-18m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB MAP3K14 ARHGEF10L GDA GRK3 DUSP16 PRKCB	2.90e-07	169	115	7	ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b
ToppCell	droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB MAP3K14 ARHGEF10L GDA GRK3 DUSP16 PRKCB	2.90e-07	169	115	7	c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DGKH DZIP3 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	2.90e-07	169	115	7	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB MRC1 HLA-DMB RGS18 GRK3 HPGDS PRKCB	3.02e-07	170	115	7	6686d1797988216c0d9417f21a2537369abce410
ToppCell	facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB MRC1 HLA-DMB RGS18 GRK3 HPGDS PRKCB	3.14e-07	171	115	7	7c4362eeacbe52d7f4fdf93c841d7b59526328c1
ToppCell	droplet-Kidney-nan-24m-Lymphocytic-lymphocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLFN14 GDA RGS18 HP MKI67 KNL1 MYBL2	3.14e-07	171	115	7	ff117bf1a0755aa7d7c3db29749a7b9b90cc0b2f
ToppCell	PND07-28-samps-Myeloid-Macrophage-CD163+_Macrophage\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	MRC1 WWP1 OAS2 RGS18 HPGDS CCL2 PRKCB	3.27e-07	172	115	7	9a659442dc41bd2a4361a7e38a7ee37a39781667
ToppCell	droplet-Kidney-nan-24m-Lymphocytic-CD45\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLFN14 GDA RGS18 HP MKI67 KNL1 MYBL2	3.27e-07	172	115	7	95219814e37259e34be053572cc95d4639360c27
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-lung_macrophage\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	USP53 MRC1 HLA-DMA HLA-DMB RGS18 CCL2 CCL13	3.67e-07	175	115	7	f5822cf48777880e670a6a18158ffb31d066c24a
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	USP53 MRC1 HLA-DMA HLA-DMB RGS18 CCL2 CCL13	3.67e-07	175	115	7	cddbd42c1cdfcdf2a41d96198ddb20e684ee6317
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	USP53 MRC1 HLA-DMA HLA-DMB RGS18 CCL2 CCL13	3.67e-07	175	115	7	067f77c5d9ae3cf960b84ece80c25d5193873cbf
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYBB HEXB MRC1 WWP1 HPGDS FTH1 CCL2	3.67e-07	175	115	7	d983e80eeb11f341c564ea684e2b0b585a90ae58
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HLA-DMB PRKCB MYH15 DTHD1 NOS1 DNAH9 HYDIN	3.67e-07	175	115	7	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYBB HEXB MRC1 HLA-DMA HPGDS FTH1 CCL2	3.82e-07	176	115	7	adb679e69c0c17f0caee4c141bac55d03c963012
ToppCell	facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB HEXB HLA-DMA HLA-DMB RND3 RGS18 GRK3	3.82e-07	176	115	7	a85ad8b4815fde72edd5c900e882a0bc04033ea8
ToppCell	facs-Trachea-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAAF4 SPATA17 DTHD1 DNAH6 DNAH9 HYDIN DNAH11	3.82e-07	176	115	7	ed788a5969edfd1199828ca5b0dd34e7f29c4d30
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYBB HEXB MRC1 HLA-DMA HPGDS FTH1 CCL2	3.97e-07	177	115	7	ab92ffc9624850a50c88e6b8f3a517ff2251ff15
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPATA17 ULK4 PPP1R36 DTHD1 DNAH9 HYDIN DNAH11	3.97e-07	177	115	7	e8bb4f8ecd5e283efec966b9fc2040a6152d5551
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYBB FNIP2 MRC1 KBTBD8 GDA MKI67 KNL1	3.97e-07	177	115	7	67cc3a6461db5e0678f96b18224aeb83ad34b0f4
ToppCell	droplet-Lung-LUNG-30m-Myeloid-intermediate_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB PTPN1 GDA GRK3 HP FTH1 RPL19	4.12e-07	178	115	7	3c1246dccdebd6f504ffdfd6eba3a676db9d2e8a
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPATA17 ULK4 PPP1R36 DTHD1 DNAH9 HYDIN DNAH11	4.12e-07	178	115	7	b1db59344c074c7c80169fc2c5cd5fc89f3fe463
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Intermediate_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB PTPN1 GDA GRK3 HP FTH1 RPL19	4.12e-07	178	115	7	25a4545dbef4246cf6d27b9b5dde24881da6887e
ToppCell	droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB PTPN1 GRK3 HP DUSP16 FTH1 RPL19	4.12e-07	178	115	7	a1f2c134bb7596f678fb4cc11405c374d926ea0f
Disease	Schizophrenia	MCHR1 ADAMTS12 PTPN1 BRCA1 HP PIK3C3 HPGDS SLC6A5 ULK4 CCL2 KCNS3 ATM NOS1	2.85e-05	883	111	13	C0036341
Disease	Primary Ciliary Dyskinesia	DNAAF4 DNAH9 HYDIN DNAH11	2.99e-05	47	111	4	C4551720
Disease	myofibrillar myopathy 5 (implicated_via_orthology)	FLNB FLNC	4.20e-05	3	111	2	DOID:0080096 (implicated_via_orthology)
Disease	distal muscular dystrophy 4 (implicated_via_orthology)	FLNB FLNC	4.20e-05	3	111	2	DOID:0111190 (implicated_via_orthology)
Disease	congestive heart failure (biomarker_via_orthology)	HP FTH1 CCL2 PRKCB NOS1	5.39e-05	107	111	5	DOID:6000 (biomarker_via_orthology)
Disease	Unipolar Depression	OAS2 DGKH HP FTH1 CCL2 PRKCB NOS1	5.78e-05	259	111	7	C0041696
Disease	Depressive disorder	MCHR1 IDO1 OAS2 BRCA1 HP FTH1 NOS1	1.15e-04	289	111	7	C0011581
Disease	Endogenous Hyperinsulinism	MRC1 PTPN1 CCL2	1.26e-04	26	111	3	C1257963
Disease	Exogenous Hyperinsulinism	MRC1 PTPN1 CCL2	1.26e-04	26	111	3	C1257964
Disease	Compensatory Hyperinsulinemia	MRC1 PTPN1 CCL2	1.26e-04	26	111	3	C1257965
Disease	Prostate cancer, familial	PPFIBP2 BRCA1 ATM KNL1	1.36e-04	69	111	4	C2931456
Disease	Lupus Erythematosus, Discoid	CYBB CR2	1.39e-04	5	111	2	C0024138
Disease	Hyperinsulinism	MRC1 PTPN1 CCL2	1.58e-04	28	111	3	C0020459
Disease	selenium measurement	ZNF14 MYOM2 ADGRL2	1.76e-04	29	111	3	EFO_0006331
Disease	age related macular degeneration (implicated_via_orthology)	CCL2 CCL13	2.08e-04	6	111	2	DOID:10871 (implicated_via_orthology)
Disease	hypertension (biomarker_via_orthology)	CYBB GRK3 HP CCL2 HSD17B4 NOS1	2.24e-04	227	111	6	DOID:10763 (biomarker_via_orthology)
Disease	obesity (biomarker_via_orthology)	MCHR1 HP CCL2 PRKCB NOS1	2.40e-04	147	111	5	DOID:9970 (biomarker_via_orthology)
Disease	Kartagener Syndrome	DNAAF4 DNAH9 HYDIN	3.11e-04	35	111	3	C0022521
Disease	Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus	DNAAF4 DNAH9 HYDIN	3.11e-04	35	111	3	C4551906
Disease	Polynesian Bronchiectasis	DNAAF4 DNAH9 HYDIN	3.11e-04	35	111	3	C4317124
Disease	Primary ciliary dyskinesia	DNAAF4 HYDIN DNAH11	3.38e-04	36	111	3	cv:C0008780
Disease	human immunodeficiency virus infectious disease (is_marker_for)	CR2 CCL2 ATM	3.38e-04	36	111	3	DOID:526 (is_marker_for)
Disease	colon cancer (biomarker_via_orthology)	REG1A MKI67 CCL2	4.29e-04	39	111	3	DOID:219 (biomarker_via_orthology)
Disease	Bipolar Disorder	MCHR1 DGKH SLC5A3 GRK3 PROKR2 PIK3C3 HPGDS ULK4	4.54e-04	477	111	8	C0005586
Disease	corneodesmosin measurement	CCL2 CCL13	4.96e-04	9	111	2	EFO_0801499
Disease	cortical surface area measurement	FNIP2 TRPM6 HEXB FLNB NCAPD3 ITCH WNT2B MAP3K14 RND3 PTPN1 KCNS3 MPHOSPH9 ADGRL2 DNAH11	5.28e-04	1345	111	14	EFO_0010736
Disease	acute necrotizing pancreatitis (implicated_via_orthology)	CCL2 NOS1	6.19e-04	10	111	2	DOID:0080998 (implicated_via_orthology)
Disease	cardiovascular system disease (is_marker_for)	HP CCL2	6.19e-04	10	111	2	DOID:1287 (is_marker_for)
Disease	severe acute respiratory syndrome (is_marker_for)	HP CCL2 IL1R1	7.45e-04	47	111	3	DOID:2945 (is_marker_for)
Disease	end stage renal disease (biomarker_via_orthology)	CYBB CCL2 NOS1	7.45e-04	47	111	3	DOID:783 (biomarker_via_orthology)
Disease	myopathy (implicated_via_orthology)	FLNB FLNC MYH15	7.92e-04	48	111	3	DOID:423 (implicated_via_orthology)
Disease	Kidney Failure, Chronic	CYBB MYH9 CCL2	7.92e-04	48	111	3	C0022661
Disease	AL amyloidosis	ULK4 DNAH11	9.03e-04	12	111	2	MONDO_0019438
Disease	pulmonary embolism (biomarker_via_orthology)	HP CCL2	9.03e-04	12	111	2	DOID:9477 (biomarker_via_orthology)
Disease	unipolar depression, sex interaction measurement	ARHGEF10L FTH1 DNAH11	9.46e-04	51	111	3	EFO_0003761, EFO_0008343
Disease	cardiomyopathy (biomarker_via_orthology)	CCL2 NOS1	1.06e-03	13	111	2	DOID:0050700 (biomarker_via_orthology)
Disease	multiple myeloma, monoclonal gammopathy	ULK4 DNAH11	1.24e-03	14	111	2	EFO_0000203, EFO_0001378
Disease	factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement	ITCH ADH7 IL1R1	1.24e-03	56	111	3	EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791
Disease	hypertension (implicated_via_orthology)	ADAMTS16 CCL2 PRKCB NOS1	1.41e-03	128	111	4	DOID:10763 (implicated_via_orthology)
Disease	nasopharynx carcinoma (is_implicated_in)	CR2 BRCA1	1.43e-03	15	111	2	DOID:9261 (is_implicated_in)
Disease	hepatic encephalopathy (biomarker_via_orthology)	CCL2 NOS1	1.43e-03	15	111	2	DOID:13413 (biomarker_via_orthology)
Disease	Insulin Resistance	MRC1 PTPN1 CCL2	1.52e-03	60	111	3	C0021655
Disease	Insulin Sensitivity	MRC1 PTPN1 CCL2	1.52e-03	60	111	3	C0920563
Disease	PROSTATE CANCER, HEREDITARY, 1	PPFIBP2 ATM KNL1	1.52e-03	60	111	3	C4722327
Disease	primary autosomal recessive microcephaly (is_implicated_in)	NCAPD3 KNL1	1.63e-03	16	111	2	DOID:0070296 (is_implicated_in)
Disease	COVID-19 (is_marker_for)	FTH1 CCL2 IL1R1	1.75e-03	63	111	3	DOID:0080600 (is_marker_for)
Disease	Allergic Reaction	HP CCL2 IL1R1	1.75e-03	63	111	3	C1527304
Disease	Hypersensitivity	HP CCL2 IL1R1	1.83e-03	64	111	3	C0020517
Disease	stomach cancer (is_marker_for)	GDA BRCA1 MKI67 ATM	2.07e-03	142	111	4	DOID:10534 (is_marker_for)
Disease	sensorineural hearing loss (implicated_via_orthology)	DNAAF4 DNAH9	2.30e-03	19	111	2	DOID:10003 (implicated_via_orthology)
Disease	hydrocephalus (implicated_via_orthology)	ULK4 HYDIN	2.30e-03	19	111	2	DOID:10908 (implicated_via_orthology)
Disease	toxic shock syndrome (is_marker_for)	IDO1 CCL2	2.30e-03	19	111	2	DOID:14115 (is_marker_for)
Disease	type 2 diabetes mellitus (biomarker_via_orthology)	HP MKI67 CCL2 NOS1	2.34e-03	147	111	4	DOID:9352 (biomarker_via_orthology)
Disease	urate measurement, bone density	TRPM6 FSIP2 RND3 SPATA17 ADAMTS16 KCNS3 DNAH9 DNAH11	2.39e-03	619	111	8	EFO_0003923, EFO_0004531
Disease	Malignant neoplasm of breast	FLNB MYH9 IDO1 KBTBD8 BRCA1 HP KCNH1 SLC6A5 MKI67 ATM DNAH9	2.43e-03	1074	111	11	C0006142
Disease	end stage renal disease (implicated_via_orthology)	CCL2 NOS1	2.55e-03	20	111	2	DOID:783 (implicated_via_orthology)
Disease	Adenocarcinoma of prostate	BRCA1 ATM	2.55e-03	20	111	2	C0007112
Disease	multiple sclerosis (is_implicated_in)	CCL2 CCL13 MPHOSPH9	2.66e-03	73	111	3	DOID:2377 (is_implicated_in)
Disease	Mental Depression	MCHR1 IDO1 OAS2 BRCA1 HP	2.78e-03	254	111	5	C0011570
Disease	skin hydration measurement	PIWIL1 DTHD1	2.81e-03	21	111	2	EFO_0009586
Disease	haptoglobin measurement	HP HYDIN	2.81e-03	21	111	2	EFO_0004640
Disease	BREAST CANCER	BRCA1 ATM	2.81e-03	21	111	2	114480
Disease	activities of daily living score measurement	PIWIL1 NOS1	2.81e-03	21	111	2	EFO_0008451
Disease	Autosomal Recessive Primary Microcephaly	NCAPD3 KNL1	3.08e-03	22	111	2	C3711387
Disease	Manic	SLC5A3 GRK3 CCL2	3.21e-03	78	111	3	C0338831
Disease	Sensorineural Hearing Loss (disorder)	MYH9 TMC1	3.37e-03	23	111	2	C0018784
Disease	airway responsiveness measurement	DZIP3 MYH15	3.67e-03	24	111	2	EFO_0006897
Disease	Dyslipidemias	HP DNAH11	3.67e-03	24	111	2	C0242339
Disease	Dyslipoproteinemias	HP DNAH11	3.67e-03	24	111	2	C0598784
Disease	Mammary Carcinoma, Human	MYH9 IDO1 BRCA1 HP KCNH1 MKI67 ATM	3.76e-03	525	111	7	C4704874
Disease	Mammary Neoplasms, Human	MYH9 IDO1 BRCA1 HP KCNH1 MKI67 ATM	3.76e-03	525	111	7	C1257931

Protein segments in the cluster

Peptide	Gene	Start	Entry
VKETVWNCPSKKQKE	TDRD5	401	Q8NAT2
KCKAAVLWEQKQPFS	ADH7	21	P40394
NQPGWLCPDEDKKSK	ARHGEF10L	761	Q9HCE6
VLQCESDPEFVQWKK	GRK3	631	P35626
IWLFPKNQCKCEANK	B4GALNT2	131	Q8NHY0
NTGKSQWEKPKFKQC	ADGRG4	2431	Q8IZF6
KEICADPKEKWVQNY	CCL13	71	Q99616
KEKGDEFCWIQDPVI	ADGRG6	1006	Q86SQ4
KWVESECPEKEKLPQ	DNAH11	3856	Q96DT5
EAEQKAGAWCKDPLQ	ADGRL2	151	O95490
SFKQKKWQDLCVGDV	ATP8B3	226	O60423
SKEWNKAVPFCESQK	DCLRE1B	406	Q9H816
FCKWQKSINPKSDLN	ADAMTS12	321	P58397
KWKPYTQVEDQDLCK	ADAMTS16	666	Q8TE57
NCWEEDPEKRPDFKK	GUCY2C	726	P25092
DKPETWENQWKCFKV	MSMO1	86	Q15800
YADCVLANWKKKDPN	IDO1	126	P14902
KGSLKCAQYWPQKEE	PTPN1	116	P18031
EIKEDTNKWKNIPCS	nan	791	O00370
KQWINKAVGDKLPEC	HP	131	P00738
CFPWAEKKQDVKEQM	HPGDS	101	O60760
LSGPKNLTWQKQCKD	IL12RB2	161	Q99665
SSWEEKPQCKKEEKN	FSIP2	6766	Q5CZC0
KDLAEDAPWKKIQQN	FLNB	6	O75369
KEIDNLVLPDCWNEK	KIAA1586	126	Q9HCI6
KEDKCWEKVEVSSNP	CUL7	836	Q14999
VKTDWNEECKSPKKG	GAREM1	346	Q9H706
KDLAEDAPWKKIQQN	FLNC	26	Q14315
RVTKGSFEPQKCWKN	DEFB125	16	Q8N687
AWEKNKSVSYEQCKP	MPHOSPH9	926	Q99550
FKQPIEDDSCKGWGK	KCNH1	136	O95259
YKPLANGSECWKKEN	LMLN2	486	A0A1B0GTW7
ICENKPKILNSEEWF	KNL1	1511	Q8NG31
CQKKFWKNPLNIIDF	KCNS3	246	Q9BQ31
SPCWKKQEQKLDDEE	KMT2B	351	Q9UMN6
KTKTIKCSLNPEWNE	PRKCB	211	P05771
ECWFPKATDKSFVEK	MYH9	531	P35579
CKDLPKSDVLQDNKW	MED17	601	Q9NVC6
CLDNSKKNESPFWKL	MKI67	226	P46013
LKSWEDKQKCDSGKP	DGKH	956	Q86XP1
LAKEAKEWLSSPCFK	OAS2	656	P29728
CWKKFKNLKYPGEND	DZIP3	291	Q86Y13
SKWEQASKEQQPGKC	PLEKHH2	1191	Q8IVE3
KWNATNKDPEELFKQ	PPFIBP2	341	Q8ND30
LNKWTRKKDFPCDQS	KBTBD8	506	Q8NFY9
KCPRFLKVKNWETEV	NOS1	301	P29475
VLKFQDPAGCQDIWK	PPP4R3C	81	Q6ZMV5
PQKFCIEKVGKENWL	ITCH	851	Q96J02
DLNADPLCERKEWNK	BRCA1	341	P38398
IFLQDIKKPDCDDWE	FTH1	81	P02794
ADEKPWCFIKVTNDK	HABP2	251	Q14520
QEDWKSLLTDCFPKI	ATM	1276	Q13315
FNKDLLTCWDPEENK	HLA-DMB	46	P28068
WLKSKFDCLDPEVLN	DNAH6	906	Q9C0G6
CEWFVQSQKPVDKLE	HYDIN	1731	Q4G0P3
DAENGIWFKKIPLCK	CR2	701	P20023
AKEICADPKQKWVQD	CCL2	71	P13500
SWKPQNAFCGDEKNK	FNIP2	641	Q9P278
PEAVKANWKKICDFE	HSD17B4	266	P51659
ANWKKICDFENASKP	HSD17B4	271	P51659
VNDSFCEKILPWLDK	DUSP16	211	Q9BY84
DKEFCEWMIQQIGPK	HLA-DMA	101	P28067
KFKWENKVFTEPQQC	DTHD1	761	Q6ZMT9
QKVCEWKEPEELKQL	CSAD	41	Q9Y600
QCWEADAKKRPSFKQ	MAP3K20	241	Q9NYL2
KKSKLHWCNNVPDIF	MCHR1	136	Q99705
CDKQEFQDAWKLPKI	CYBB	371	P04839
CDLKEEEKNPEWLKD	DNAAF4	281	Q8WXU2
QEKLAKEWCFKPCEI	GDA	51	Q9Y2T3
ECPEKEKLPQEWKNK	DNAH9	3831	Q9NYC9
VEFKCWESNPKIQDF	HEXB	356	P07686
ENNELPKLQWYKDCK	IL1R1	151	P14778
FQKWKDVPCEDKFSF	REG1A	146	P05451
DSVLKKWKGEIQEFC	RND3	111	P61587
EKSPVFCGKWEILND	MAP3K14	46	Q99558
PGKNAKWENLECVQK	MRC1	321	P22897
DIDWDQNPKSTFKKA	PIWIL1	321	Q96J94
IKKESCFWPEENANT	GPRASP1	351	Q5JY77
EWSLCAVAATQKKKP	GOLGA8A	201	A7E2F4
EQFRSENPKKWICDK	SPATA17	321	Q96L03
ENPKKWICDKDFQTV	SPATA17	326	Q96L03
SKEVVGCKWEKVNPD	SLFN14	251	P0C7P3
NECDSYKKKHLNVWP	TMC3	891	Q7Z5M5
WEKVCNFQAKPDDLI	SULT1C3	36	Q6IMI6
KPEPDDLCCVKWKEN	TDRD6	536	O60522
KTWNKNDFKPQCKRT	SPATA22	121	Q8NHS9
CNNPWNTPECKDKTK	SLC6A5	311	Q9Y345
KKKCWIPDGENAYIE	MYH15	51	Q9Y2K3
DVPEQRDSKCKVKWT	MYBL2	21	P10244
TKFLKCVNWDLPQEA	PIK3C3	331	Q8NEB9
RCGKKKVWLDPNETN	RPL19	16	P84098
PVWKKCLEEQGLKFV	CTPS1	486	P17812
FWSKKNLVVKENCSP	SLC5A3	546	P53794
CKPWNFGQFEKNVLD	TGM4	176	P49221
EFFDDPKNWGQEKVK	MRPL47	66	Q9HD33
ENFKAACVPWENKIK	TMC1	161	Q8TDI8
DKCIQTLKKSWPQES	NCAPD3	141	P42695
EWEKVAQLCDFNPKS	CLTB	191	P09497
EQKLEKPNECKFSEW	USP53	816	Q70EK8
KPNECKFSEWLNIEN	USP53	821	Q70EK8
SVLKKWQGETQEFCP	RND2	96	P52198
PVKFHEAWQKLCKAD	CTPS2	351	Q9NRF8
LCELFNWLEKEVPKG	XPNPEP1	341	Q9NQW7
FSQEEWKCLEPVQKA	ZNF616	16	Q08AN1
CISEPGKFTQKVKVW	TRPM6	891	Q9BX84
KNLACIGEKWKDQDI	ZNF490	91	Q9ULM2
WIACEDFKKSKGPQQ	RGS18	116	Q9NS28
CQQKALKKDEGVPWT	PHF21B	396	Q96EK2
VEEKPTKENWKNCIQ	TPP2	1206	P29144
NPCSKLKGETAWQKF	TOP1MT	266	Q969P6
EFSQEEWKCLDPGQK	ZNF534	16	Q76KX8
NEGKCDLKEKWFGTQ	NRDC	616	O43847
KSQEKIFCGQIWPVD	PROKR2	201	Q8NFJ6
CGKEKISDTQKDWKF	PPP1R36	221	Q96LQ0
KWESIPNTEKSYKCD	ZNF655	201	Q8N720
QKFCIEKVGKDTWLP	WWP1	871	Q9H0M0
VHTCKAPKKAEWLDQ	WNT2B	376	Q93097
ATQEEKKKNPRECWA	ULK4	586	Q96C45
TFKNLVCLGKKWEDQ	ZNF14	36	P17017
AWLQICEPTEKDKGK	MYOM2	1286	P54296